These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 812047)

  • 41. [The clinical evaluation of cytotoxic agents based on their inhibition of tumor growth in vitro].
    Izsak FC; Eylan E; Shapiro J; Naharin A
    Harefuah; 1971 Feb; 80(3):126-8. PubMed ID: 4999822
    [No Abstract]   [Full Text] [Related]  

  • 42. [On quantitative changes in the leukocytes and thrombocytes after chemotherapy in patients with malignant tumors of the ovaries].
    Livshits MA
    Vopr Onkol; 1966; 12(8):42-6. PubMed ID: 4972210
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of advanced inoperable carcinoma of the ovaries (author's transl)].
    Senn HJ
    Ther Umsch; 1973 Sep; 30(9):651-6. PubMed ID: 4584458
    [No Abstract]   [Full Text] [Related]  

  • 44. [Results of treatment of 320 patients with malignant ovarian neoplasms].
    Taubert W; Prager W
    Dtsch Gesundheitsw; 1972 Jun; 27(25):1175-80. PubMed ID: 5066456
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic results of advanced malignant ovarian tumours].
    Taubert W; Prager W
    Radiobiol Radiother (Berl); 1973; 14(1):11-6. PubMed ID: 4689204
    [No Abstract]   [Full Text] [Related]  

  • 46. Chemotherapy in the treatment of ovarian cancer.
    Limburg HG
    Proc R Soc Med; 1969 Apr; 62(4):361-2. PubMed ID: 4980488
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of ovarian carcinoma: a review of 14 years' experience at Beth Israel Hospital.
    Blinick G; Kabakow B; Antopol W; Wallach RC
    Mt Sinai J Med; 1972; 39(5):447-57. PubMed ID: 4628079
    [No Abstract]   [Full Text] [Related]  

  • 48. [Possible incompatibility of deep radiotherapy and high-dose adriamycin or cyclophosphamide therapy in advanced genital tumors of the female].
    Wolf A; Bork E; Vahrson H
    Strahlentherapie; 1976 Nov; 152(5):422-6. PubMed ID: 996885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
    Ohta M; Tomoda Y; Kano T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Our experiences with cytostatics in cases of malignant ovarian tumors].
    Ferkó S; Gál I; Szönyi I
    Orv Hetil; 1967 Mar; 108(11):496-8. PubMed ID: 6047073
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experiences with cyclophosphamide and x-ray combination therapy in ovarian neoplasms].
    Schultze H; Weise W
    Radiobiol Radiother (Berl); 1971; 12(2):173-81. PubMed ID: 4110089
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of radiotherapy and chemotherapy on the granulocytic reserve of the bone marrow in cancer of the genitalia].
    Kosareva AN; Turbina IL; Urvantseva NV
    Vopr Onkol; 1971 Dec; 17(12):38-9. PubMed ID: 5004141
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans].
    Neĭshtadt EL; Gnilevskaia ZU; Aĭnbinder NM
    Vopr Onkol; 1975; 21(7):48-53. PubMed ID: 814712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment results of ovarian neoplasms during the years 1960-5].
    Matýsek P; Slot E; Uher M
    Cesk Gynekol; 1971 Oct; 36(8):459-61. PubMed ID: 5119855
    [No Abstract]   [Full Text] [Related]  

  • 55. Thio-tepa chemotherapy for ovarian carcinoma. Influence of remission and toxicity on survival.
    Wallach RC; Kabakow B; Blinick G; Antopol W
    Obstet Gynecol; 1970 Feb; 35(2):278-86. PubMed ID: 4189962
    [No Abstract]   [Full Text] [Related]  

  • 56. [The treatment of ovarian carcinoma in the Univ.-Frauenklinik Tübingen since 1957 and its results].
    Pfleiderer A; Kiyan S
    Med Welt; 1967 Dec; 51():3095-102. PubMed ID: 5608859
    [No Abstract]   [Full Text] [Related]  

  • 57. [Endolymphatic polychemotherapy of ovarian cancer].
    Pankov AK; Sidorenko IuS; Il'inskaia EG; Ogorodnikova LS; Zubkova TV
    Vopr Onkol; 1981; 27(1):84-8. PubMed ID: 6779424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas.
    Malkasian GD; Webb MJ; Jorgensen EO
    Obstet Gynecol; 1974 Dec; 44(6):885-8. PubMed ID: 4437825
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diagnostic and prognostic importance of the polyamine test of patients with ovarian tumors].
    Draga NV; Berdinskikh NK; Zaletok SP; Vinnitskaia VK; Evtushenko GV
    Vopr Onkol; 1987; 33(4):52-7. PubMed ID: 3590659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of the individual sensitivity of ovarian ascitic cancer cells in vitro by cytological criteria].
    Shuvaeva NI; Antoshechkina ET; Klimanova ZF
    Vopr Onkol; 1979; 25(7):101-4. PubMed ID: 113933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.